Ecuador vs El Salvador: Previously treated cases tested for RR-/MDR-TB
Ecuador
97.0%
in 2024
El Salvador
97.0%
in 2024
Ecuador rank
61st
El Salvador rank
61st
Previously treated cases tested for RR-/MDR-TB over time
- Ecuador
- El Salvador
How they compare
Ecuador currently reports 97.0% against 97.0% in El Salvador, a difference of 0.0%.
The two have swapped places 3 times across 13 shared years of data; in 2005 it was Ecuador ahead.
Ecuador ranks 61st and El Salvador ranks 61st of 180 countries.
Ecuador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 67.3% | 67.0% | 0.3% | Ecuador |
| 2010s | 85.6% | 49.2% | 36.4% | Ecuador |
| 2020s | 97.3% | 42.0% | 55.4% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ecuador or El Salvador?
- Ecuador, at 97.0% against 97.0% in El Salvador as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ecuador and El Salvador?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and El Salvador?
- 13 years are reported by both, from 2005 to 2024.
- How do Ecuador and El Salvador rank globally for previously treated cases tested for rr-/mdr-tb?
- Ecuador ranks 61st and El Salvador ranks 61st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.